The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The landscape of precision medicine cancer clinical trials in the United States.
Nitin Roper
No relevant relationships to disclose
Kristian Stensland
No relevant relationships to disclose
Ryan Hendricks
No relevant relationships to disclose
Matt D. Galsky
No relevant relationships to disclose